Generate Biomedicines, Inc. cotiza a 12.26 USD y tiene una capitalización bursátil de $1.6B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development. Its product includes GB-0895, is an investigational long…
| Periodo | 2026-11 | 2026-08 | 2026-05 |
|---|---|---|---|
| Real | — | $-0.52 | $-1.07 |
| Estimado | $-0.58 | $-0.49 | $-0.51 |
| Sorpresa | — | -6.1% | -109.8% |
| Métrica | GENB | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | — | -32.0% | — |
| Current Ratio | 2.85 | 2.84 | +0.01 |
| Debt / Equity | — | 0.28 | — |